Article

High neutrophils and triglycerides lead to critical illness in COVID-19 and reveal CDK6 inhibitors as potential treatment

2022-03-23

Abstract excerpt

Despite the recent development of vaccines and monoclonal antibodies preventing SARS-CoV-2 infection, treating critically ill COVID-19 patients still remains a top goal. In principle, drug repurposing -- the use of an already existing drug for a new indication -- could provide a shortcut to a treatment. However, drug repurposing is often very speculative due to lack of clinical evidence. We report here on a method...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 3829c41a-8a93-53fe-a737-fe1c57f6e3a5
DOI: 10.21203/rs.3.rs-1469211/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

High neutrophils and triglycerides lead to critical illness in COVID-19 and reveal CDK6 inhibitors as potential treatmentDOI 10.21203/rs.3.rs-1469211/v1Read

Critically ill COVID-19 status associated trait genetics reveals CDK6 inhibitors as potential treatmentSemantic proximity Read

Neutrophils cause critical illness in COVID-19 and reveal CDK6 inhibitors as potential treatmentSemantic proximity Read

Recognition of plausible therapeutic agents to combat COVID-19: An omics data based combined approachSemantic proximity Read

GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19.Semantic proximity Read

Identification and evaluation of candidate COVID-19 critical genes and medicinal drugs related to plasma cellsSemantic proximity Read

Safeguarding COVID-19 and cancer management: drug design and therapeutic approachSemantic proximity Read

Five Critical Genes Related to Seven COVID-19 Subtypes: A Data Science DiscoverySemantic proximity Read

Translating GWAS Findings to Inform Drug Repositioning Strategies for COVID-19 TreatmentSemantic proximity Read

Single-nucleus lung transcriptomics and inflammatory responses in lethal COVID-19 reveal potential drugs in advanced-stage clinical trialsSemantic proximity Read

Multi-omics data integration and network-based analysis drives a multiplex drug repurposing approach to a shortlist of candidate drugs against COVID-19Semantic proximity Read

COVID-19: A Drug Repurposing and Biomarker Identification by Using Comprehensive Gene-Disease Associations through Protein-Protein Interaction Network AnalysisSemantic proximity Read

Drug Repurposing of potential drug targets for treatment of COVID-19Semantic proximity Read